Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

NCT01513603 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Burkitts Leukemia/Lymphoma
Chronic Myelogenous Leukemia

Interventions

DRUG: CLAG-M
DRUG: CLAG-M

Sponsor

New York Medical College